#52026XC010441 Ocak 2026'dan 31 Ocak 2026'a kadar sağlık ürünleri ile ilgili pazarlama izinlerine dair Avrupa Birliği kararlarının özeti
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
🇬🇧 English
This law outlines the European Union's decisions regarding the approval of medicinal products for marketing between January 1, 2026, and January 31, 2026. It affects pharmaceutical companies seeking to market new medicines in the EU and ensures compliance with established regulations for safety and efficacy.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- New guidelines for the evaluation of medicinal products
- Updated timelines for marketing authorisation processes
- Enhanced requirements for safety data submission
+ 1 more changes with Pro
Affected Parties
Pharmaceutical companiesHealthcare providers+1 more…
Tags
medicinal products,marketing authorisation,EU regulations…